Postes actifs de Marc Dechamps
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Directeur/Membre du Conseil | 19/06/2024 | - |
| Independent Dir/Board Member | 19/06/2024 | - |
Historique de carrière de Marc Dechamps
Anciens postes connus de Marc Dechamps
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Delphi Genetics SA
 Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Directeur Général | - | 01/07/2017 |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Belgique | 3 |
| France | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Entreprise privées | 2 |
|---|---|
Delphi Genetics SA
Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
- Bourse
- Insiders
- Marc Dechamps
- Expérience
